AI-washing – when AI hype becomes a litigation risk
We have a balanced practice advising strategic investors, financial investors as well as emerging companies at any stage of the "venture capital lifecycle" - whether early, mid-stage or late stage and growth equity or last dollars before an exit, and beyond.
This means that we have a unique ability to understand perspectives from all sides of the table which is critical in developing solutions that help investors and innovators stay ahead of the curve.
Our lawyers are highly experienced in their local markets and are firmly embedded within their local ecosystems, but also connected with each other in sharing ideas and opportunities, leveraging our unique worldwide reach and capability to provide international insight to our clients.
Fast growth businesses are transforming every industry with disruptive business models. Our industry focus enables us to identify, and anticipate regulatory changes, market dynamics, and trends that will redefine the shape of an industry. We have our finger on the pulse. We can help spot investment opportunities and support growth companies to learn and change.
Our world leading regulatory expertise means we don't just understand regulation; we can shape it, challenge it and navigate it. Just as we can help investors to understand, identify and deal with regulatory risks affecting their investments, we can help growth businesses leverage regulation to become stronger where it matters.
Hear from our clients and industry leaders
Hogan Lovells houses a respected venture capital team with experience ranging from seed financing to later-stage rounds, often acting for well-known investors as well as startups.”
Chambers Germany, 2026
The “first-rate”, “knowledgeable” team at Hogan Lovells is regularly called upon by sovereign wealth funds, institutional investors, strategic investors, portfolio companies, and management teams for its venture and growth capital expertise."
Legal 500 EMEA, 2025
Key contacts
Representative experience
6
6
Apis Global Growth Fund III as lead investor on a c.£70m investment in Moneybox, one of the UK’s fastest growing and highly profitable digital wealth management platforms.
Rice University on its launch of RBL LLC, a biotech venture creation studio developed out of the Rice Biotech Launch Pad, the university’s biotech innovation accelerator.
FlixMobility on all financing rounds, including its US$650m Series G financing, valued at US$3bn.
Tazapay, a Singapore-based global cross border payments infrastructure platform, on the successful close of its Series B funding round led by Peak XV Partners and its Series B extension round led by Circle Ventures.
Iberis Capital, a Portugal-based private equity and venture capital firm, on its Series C investment in Kevel, a United States-based application programing interface (API)-led ad-serving company.
OncoVerity, a pioneer in applying advanced bioinformatics to drug development, on the closing of a Series A extension financing led by existing investors, argenx and RefinedScience.
Avelios Medical, a Germany-based software company digitalizing hospital workflows and data driven patient care, on its €30m Series A funding round led by Sequoia Capital.
Xora Innovation, a Singapore-based venture capital firm, as a lead investor in the US$200m Series A funding round of Upscale AI, a high performance AI networking infrastructure company.
Navigate change with our latest insights
.jpg?sc_lang=en)
Form now, pay later - How does Luxembourg bring more flexibility to the minimum share capital payment for SARLs?
29 April 2026
Mitigating tax risks on secondary transactions
24 March 2026
Defence sector – tackling the barriers to securing finance – EU and UK
18 March 2026
You may also be interested in...
Press releases
Catalyst for strategic investment: Hogan Lovells advises Limehome on €75 million investment by Cheyne Strategic Value Credit
28 January 2026
Press releases
Hogan Lovells advises HF Private Debt on successful exit from ENTRO Service GmbH
08 October 2025
Press releases
Hogan Lovells advises investors on multi-million financing for start-up EEDEN
06 May 2025
Press releases
Next Level Procurement: Hogan Lovells advises Beroe on the acquisition of AI start-up nnamu
22 April 2025
Press releases
Hogan Lovells advises KIRKBI on the acquisition of a minority stake in AMBOSS
01 April 2025
Press releases
Hogan Lovells advises Medicud on the seed round with international investors
19 February 2025
Press releases
Hogan Lovells advises Avelios Medical on EUR 30 million financing round led by Sequoia Capital
06 February 2025
Press releases
Hogan Lovells advises CDP Venture Capital in its investment in Mela Works
26 September 2024
Press releases
Hogan Lovells advises CatalYm on a USD 150 million venture capital funding round
29 July 2024
Press releases
Hogan Lovells advises Flipkart on adding Google as an investor in its latest funding round
13 June 2024
Sponsorships and Speaking Engagements
BIO International Convention
3-6 June 2024 | 10:00 a.m. - 5:00 p.m. (PT)
Press releases
Hogan Lovells advises Sartorius Group on a cooperation and minority shareholding in TheWell Bioscience Inc.
19 April 2024
Press releases
Hogan Lovells advises Armira Growth on €25 million investment in osapiens
06 October 2023
Press releases
Navigating the opportunities and challenges that foreign companies face in China
19 July 2023
Press releases
Hogan Lovells advises various investors in the €40 million fundraising of The Exploration Company
09 February 2023
Sponsorships and Speaking Engagements
Biotech Showcase and exclusive reception during the J.P. Morgan 41st Annual Healthcare Conference
9-12 January 2023
Press releases
Hogan Lovells welcomes the New Year with 27 new partner and 71 new counsel promotions
05 January 2022
Sponsorships and Speaking Engagements
BIO International Convention
3-6 June 2024 | 10:00 a.m. - 5:00 p.m. (PT)
Sponsorships and Speaking Engagements
Biotech Showcase and exclusive reception during the J.P. Morgan 41st Annual Healthcare Conference
9-12 January 2023
Press releases
Catalyst for strategic investment: Hogan Lovells advises Limehome on €75 million investment by Cheyne Strategic Value Credit
28 January 2026
Press releases
Hogan Lovells advises HF Private Debt on successful exit from ENTRO Service GmbH
08 October 2025
Press releases
Hogan Lovells advises investors on multi-million financing for start-up EEDEN
06 May 2025
Press releases
Next Level Procurement: Hogan Lovells advises Beroe on the acquisition of AI start-up nnamu
22 April 2025
Press releases
Hogan Lovells advises KIRKBI on the acquisition of a minority stake in AMBOSS
01 April 2025
Press releases
Hogan Lovells advises Medicud on the seed round with international investors
19 February 2025
Press releases
Hogan Lovells advises Avelios Medical on EUR 30 million financing round led by Sequoia Capital
06 February 2025
Press releases
Hogan Lovells advises CDP Venture Capital in its investment in Mela Works
26 September 2024
Press releases
Hogan Lovells advises CatalYm on a USD 150 million venture capital funding round
29 July 2024
Press releases
Hogan Lovells advises Flipkart on adding Google as an investor in its latest funding round
13 June 2024
Press releases
Hogan Lovells advises Sartorius Group on a cooperation and minority shareholding in TheWell Bioscience Inc.
19 April 2024
Press releases
Hogan Lovells advises Armira Growth on €25 million investment in osapiens
06 October 2023
Press releases
Navigating the opportunities and challenges that foreign companies face in China
19 July 2023
Press releases
Hogan Lovells advises various investors in the €40 million fundraising of The Exploration Company
09 February 2023
Press releases
Hogan Lovells welcomes the New Year with 27 new partner and 71 new counsel promotions
05 January 2022
